Janaki Veeraraghavan

Neuroscience · Life Sciences

5h-index631citations19works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Axon Guidance and Neuronal Signaling(16), Angiogenesis and VEGF in Cancer(6), Apelin-related biomedical research(5), Cancer Immunotherapy and Biomarkers(2), Pancreatic and Hepatic Oncology Research(2)

Publications19 total

Supplementary Figures 1-8 from Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies
2023Open Access
Data from Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies
2023Open Access
Supplementary Methods and Figure Legends from Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies
2023Open Access
Supplementary Methods and Figure Legends from Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies
2023Open Access
Supplementary Figures 1-8 from Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies
2023Open Access
Data from Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies
2023Open Access
Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public Health
The Oncologist·2021· 81 citedOpen Access
Translating Immuno-oncology Biomarkers to Diagnostic Tests: A Regulatory Perspective
Methods in molecular biology·2019· 2 cited
FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD-L1
The Oncologist·2018· 224 citedOpen Access
Abstract A119: Antibody blockade of Semaphorin 4D neutralizes barrier to immune infiltration and facilitates immune-mediated tumor rejection
Cancer Immunology Research·2016
Antibody blockade of semaphorin 4D breaks down barriers to enhance tumoricidal immune infiltration and supports rational immunotherapy combinations
Journal for ImmunoTherapy of Cancer·2015· 3 citedOpen Access
Abstract A67: Phase 1 study of VX15/2503, an immunomodulatory antibody to Semaphorin 4D that reverses tumor growth in preclinical studies
Cancer Immunology Research·2015
Abstract 278: Antibody blockade of semaphorin 4D promotes infiltration of activated tumor infiltrating leukocytes and reverses tumor growth
Cancer Research·2015
Antibody blockade of semaphorin 4D promotes infiltration of activated tumor infiltrating leukocytes and inhibits tumor growth. (TUM7P.1030)
The Journal of Immunology·2015
Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease
Neurobiology of Disease·2015· 104 citedOpen Access
Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies
Cancer Immunology Research·2015· 105 citedOpen Access
Antibody blockade of Semaphorin 4D breaks down barriers to enhance tumoricidal immune infiltration and supports rational immunotherapy combinations
Faculty of 1000 Research Ltd·2015Open Access
SEMA4D compromises blood–brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease
Neurobiology of Disease·2014· 112 citedOpen Access
Abstract 5030: Antibody blockade of Semaphorin 4D promotes tumor rejection and improves response to immune checkpoint blockade and chemotherapy
Cancer Research·2014

Frequent Co-authors

Alan S. Jonason(16), Maurice Zauderer(16), Terrence L. Fisher(15), Crystal Mallow(15), Holm Bußler(15), Sebold Torno(15), Renee Kirk(15), Alan Howell(15), Elizabeth E. Evans(15), Christine Reilly(14), Maria Scrivens(14), Laurie A. Winter(12), William J. Bowers(11), Ernest Smith(10), Jennifer Seils(10), Mark Paris(9), Michael A. Doherty(9), Katya Klimatcheva(9), John E. Leonard(8), Susan Giralico(8)